Palau vs South Asia: Immunization, Hib3
Palau
99.0%
in 2024
South Asia
94.5%
in 2024
Palau rank
1st
South Asia rank
1st
Immunization, Hib3 over time
- Palau
- South Asia
How they compare
Palau currently reports 99.0% against 94.5% in South Asia, a difference of 4.5%.
The two have swapped places 2 times across 27 shared years of data; in 1998 it was Palau ahead.
Palau ranks 1st and South Asia ranks 1st of 191 countries.
Palau has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Palau | South Asia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 85.0% | 0.0% | 85.0% | Palau |
| 2000s | 90.2% | 1.1% | 89.1% | Palau |
| 2010s | 90.5% | 50.6% | 39.9% | Palau |
| 2020s | 91.0% | 90.6% | 0.4% | Palau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Palau or South Asia?
- Palau, at 99.0% against 94.5% in South Asia as of 2024.
- What is the difference in immunization, hib3 between Palau and South Asia?
- 4.5%, with Palau ahead.
- How many years of comparable data are there for Palau and South Asia?
- 27 years are reported by both, from 1998 to 2024.
- How do Palau and South Asia rank globally for immunization, hib3?
- Palau ranks 1st and South Asia ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.